Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

The Canadian Bioceutical CBICF

MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannab


GREY:CBICF - Post by User

Comment by Kmd001 on Oct 21, 2018 7:37am
221 Views
Post# 28842715

RE:RE:RE:RE:Number of IAN shares MPX shareholders will get

RE:RE:RE:RE:Number of IAN shares MPX shareholders will getBetter yet-  read the Sedar filings and listen to the conference call,. The exchange ratio is fixed. The exchange ratio is not changing based on stock price movement. The exchange ratio is .1673 shares of iAnthus for every MPX share, plus you get MPXI.

If you think some comment you are misintepreting on some youtube video is more impactful than a Sedar filing or a conference call with the CEOs announcing the plan of arrangement to analysts, you are quite simply ill-informed and wrong. 
<< Previous
Bullboard Posts
Next >>